• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    FDA says it needs a little more time to decide on Merck`s P2X3 for chronic cough

    ENDPTS

    2 pathways deal a one-two punch to melanoma cells

    FIERCEBIOTECH

    Merck partners with Innervia on bioelectronic therapy development

    PHARMATIMES

    Gilead files long-acting HIV med for patients with few options

    FIERCEBIOTECH

    Metabolon Announces Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany

    PRNEWSWIRE

    Germany`s Merck seeks partners for cancer and immune system drugs

    REUTERS

    Merck Begins Tender Offer to Acquire Cubist

    Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers

    Bayer fails last-ditch attempt to block India`s cheap Nexavar copies

    FIERCE PHARMA

    Did Merck Pay $3B Too Much For Cubist? Weighing the Impact of Cubicin Patent Loss

    FIERCE PHARMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.